Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Current Medicinal Chemistry
|
March 14, 2008
The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors
Eddine Saiah
Current Topics in Medicinal Chemistry
|
December 27, 2005
Small molecule coagulation cascade inhibitors in the clinic
Eddine Saiah, Chris Soares
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2013
Recent developments in targeting protein misfolding diseases
Rajiah Aldrin Denny, Lori Krim Gavrin, Eddine Saiah
Journal of Medicinal Chemistry
|
October 19, 2012
Small molecules that target protein misfolding
Lori Krim Gavrin, Rajiah Aldrin Denny, Eddine Saiah
Organic Letters
|
December 6, 2002
Ketene dithioacetals in the aza-Diels-Alder reaction with N-arylimines: a versatile approach to tetrahydroquinolines, 2,3-dihydro-4-quinolones, and 4-quinolones
Dai Cheng, Jinglan Zhou, Eddine Saiah, et al.
Journal of Medicinal Chemistry
|
September 19, 2003
Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists
Erin K Bradley, Jennifer L Miller, Eddine Saiah, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
Chemistry and biology of the 2 beta-alkyl-3 beta-phenyl analogues of cocaine: subnanomolar affinity ligands that suggest a new pharmacophore model at the C-2 position
A P Kozikowski, M K Eddine Saiah, K M Johnson, et al.
Scientific Reports
|
March 13, 2019
Discovery of NV-5138, the first selective Brain mTORC1 activator
Shomit Sengupta, Emilie Giaime, Sridhar Narayan, et al.
Nature Communications
|
February 9, 2018
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Sarah J Mahoney, Sridhar Narayan, Lisa Molz, et al.
Plos One
|
August 29, 2022
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapy
Sophie St-Cyr, Daniel D Child, Emilie Giaime, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Current Medicinal Chemistry
|
March 14, 2008
The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors
Eddine Saiah
Current Topics in Medicinal Chemistry
|
December 27, 2005
Small molecule coagulation cascade inhibitors in the clinic
Eddine Saiah, Chris Soares
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2013
Recent developments in targeting protein misfolding diseases
Rajiah Aldrin Denny, Lori Krim Gavrin, Eddine Saiah
Journal of Medicinal Chemistry
|
October 19, 2012
Small molecules that target protein misfolding
Lori Krim Gavrin, Rajiah Aldrin Denny, Eddine Saiah
Organic Letters
|
December 6, 2002
Ketene dithioacetals in the aza-Diels-Alder reaction with N-arylimines: a versatile approach to tetrahydroquinolines, 2,3-dihydro-4-quinolones, and 4-quinolones
Dai Cheng, Jinglan Zhou, Eddine Saiah, et al.
Journal of Medicinal Chemistry
|
September 19, 2003
Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists
Erin K Bradley, Jennifer L Miller, Eddine Saiah, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
Chemistry and biology of the 2 beta-alkyl-3 beta-phenyl analogues of cocaine: subnanomolar affinity ligands that suggest a new pharmacophore model at the C-2 position
A P Kozikowski, M K Eddine Saiah, K M Johnson, et al.
Scientific Reports
|
March 13, 2019
Discovery of NV-5138, the first selective Brain mTORC1 activator
Shomit Sengupta, Emilie Giaime, Sridhar Narayan, et al.
Nature Communications
|
February 9, 2018
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Sarah J Mahoney, Sridhar Narayan, Lisa Molz, et al.
Plos One
|
August 29, 2022
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapy
Sophie St-Cyr, Daniel D Child, Emilie Giaime, et al.
Page
of 4